Clinical Trial Update: Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in adolescents with Type 1 diabetes conducted by the University of Cambridge has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Cambridge | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED